So Young Kwon is SVP, GC, BD & Corp Affairs of Aptevo Therapeutics Inc.. Currently has a direct ownership of 588 shares of APVO, which is worth approximately $452. The most recent transaction as insider was on May 31, 2024, when has been sold 42 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 588
97.55% 3M change
91.98% 12M change
Total Value Held $452

SoYoung Kwon Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2024
BUY
Exercise of conversion of derivative security
-
42 Added 6.67%
588 Common Stock
Mar 03 2024
BUY
Exercise of conversion of derivative security
-
3,667 Added 13.23%
24,042 Common Stock
Mar 02 2024
BUY
Exercise of conversion of derivative security
-
3,667 Added 15.25%
20,375 Common Stock
Aug 08 2023
BUY
Exercise of conversion of derivative security
-
9,375 Added 35.94%
16,708 Common Stock
May 31 2023
BUY
Exercise of conversion of derivative security
-
1,834 Added 20.01%
7,333 Common Stock
Mar 03 2023
BUY
Exercise of conversion of derivative security
-
3,666 Added 40.0%
5,499 Common Stock
Jun 01 2022
BUY
Exercise of conversion of derivative security
-
1,833 Added 50.0%
1,833 Common Stock
SK

So Young Kwon

SVP, GC, BD & Corp Affairs
Seattle, WA

Track Institutional and Insider Activities on APVO

Follow Aptevo Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APVO shares.

Notify only if

Insider Trading

Get notified when an Aptevo Therapeutics Inc. insider buys or sells APVO shares.

Notify only if

News

Receive news related to Aptevo Therapeutics Inc.

Track Activities on APVO